Gynaecological neoplasms are the total name of tumours in the female reproductive system, including tumours in the uterus, ovaries, ovaries, vaginas and vaginas. By its very nature, gynaecological tumours can be classified as benign and malignant, and malignant tumours are often referred to as gynaecological cancers. Knowledge of the type of gynaecology tumours, symptoms and methods of prevention is essential for women ‘ s health.
I. Common gynaecologically benign tumours
1. Cervical musculoma
Brief description: The uterine musculoma is the most common gynaecological benign neoplasm, most of which is found in women aged 30 to 50 years, and is formed by uterine cell growth.
Symptoms: Some patients have no apparent symptoms, and those with symptoms may be characterized by multiple months, extended menstruation, abdominal blocks or oppressive symptoms (e.g. urine frequency, constipation).
Treatment: small, non-symptomatic myoomas can be observed and followed; a musculoma with visible or rapidly growing symptoms can be considered for medication or surgical treatment (e.g. utero hysterectomy or myooma removal).
2. ovarian cysts
Brief: The ovarian cyst is a liquid or semi-liquid cystalosis within the ovarian, divided into functional cysts and non-functional cysts.
Symptoms: usually without symptoms and incidentally detected during a medical examination; if the cyst is larger, it may cause abdominal swelling, abdominal pain or arrhythmia.
Treatment: Small functional cysts can be reduced by themselves; larger or growing cysts may require surgical treatment.
II. Common malignant neoplasms
Cervical cancer
Profile: Cervical cancer is one of the most common gynaecological malignant neoplasms, mainly caused by the continuous infection of the high-risk human papilloma virus (HPV).
Symptoms: Early symptoms are not visible and may be manifested only in contact with sexual or irregular vaginal haemorrhage; pelvis pain or urination difficulties can occur in late stages.
Prevention: Vaccination against HPV, periodic screening for cervical cancer (e.g. cervical cytology and HPV testing).
Treatment: Early use of surgery or treatment, and late stage of joint chemotherapy.
2. ovarian cancer
Brief: ovarian cancer is known as the “silent killer” whose early symptoms are hidden and often diagnosed to an advanced stage.
Symptoms: abdominal swelling, reduced appetite, reduced body weight, pelvis or abdominal pain.
High-risk factors: family history, history of infertility, unborn or older births.
Treatment: Surgery tumour combination chemotherapy; some patients receive targeted treatment.
3. Endeminal uterine cancer
Profile: Endomeal cancer is a malignant tumour in the uterus, most of which is found in post-menopausal women and is often associated with obesity, infertility and high estrogen levels.
Symptoms: Irregular vaginal haemorrhage (especially post-menopausal haemorrhage), lower abdominal pain or pelvic oppression.
Treatment: Early surgery is the main focus, and final joint chemotherapy.
4. Vulva and vaginal cancer
Brief: These are relatively rare and are usually associated with HPV infections or chronic chronic chronic diseases with chronic genitals.
Symptoms: Anomalous haemorrhage, itching or ulcer in the genital or vagina, possibly accompanied by local swelling.
Treatment: Surgery combined with treatment or chemotherapy.
III. How to prevent gynaecological tumours
1. Periodic medical examinations
Annual gynaecological examinations, including pelvic examinations, ultrasound examinations and cervical cancer screening (cervix smears or HPV tests), are conducted.
2. Vaccination
Vaccination against HPV can effectively prevent cervical cancer and some other HPV-related cancers.
3. Healthy lifestyles
A reasonable diet: Eat more fresh vegetables and fruits and reduce the intake of high-fat sugar.
Moderate exercise: to keep body weight within health and reduce the risk of tumours associated with obesity.
Prohibition of alcohol: Both smoking and drinking can increase the risk of certain cancers.
4. Knowledge of family history
If the family has a history of ovarian or breast cancer, it should be alert to genetic tumour syndrome (e.g., mutation of the BRCA gene) and, if necessary, genetic testing.
IV. Science in the face of gynaecology
Attention to early detection: Early symptoms of gynaecological malignant tumours are often unusual, so regular screening is key to detecting early pathologies.
Reasonable view of treatment: Even when malignant tumours are diagnosed, modern medicine provides a variety of treatments, such as surgery, treatment, chemotherapy and target treatment.
Concluding remarks
Gynaecology tumours are not terrible, but the key is scientific prevention, early detection and normative treatment. Health care, regular medical check-ups and healthy lifestyle choices are effective ways of safeguarding women ‘ s health. In the event of an unspecified gynaecology condition, prompt medical treatment should be provided without neglecting any possible health warnings.
Let’s start with scientific awareness and care for women’s beauty and health together!
Gynaecology cancer
